BC
Birchview Capital Portfolio holdings
AUM
$176M
1-Year Est. Return
95.04%
This Fund
S&P 500
1 Year Est. Return
+95.04%
AUM
$176M
AUM Growth
+$4.87M
(+2.8%)
Holding
85
Top Buys
| 1 | +$3.05M | |
| 2 | +$2.52M | |
| 3 | +$2.23M | |
| 4 |
Relmada Therapeutics
RLMD
|
+$1.94M |
| 5 |
Celldex Therapeutics
CLDX
|
+$1.91M |
Top Sells
| 1 | +$3.6M | |
| 2 | +$2.93M | |
| 3 | +$2.22M | |
| 4 |
Immunome
IMNM
|
+$1.78M |
| 5 |
Protagonist Therapeutics
PTGX
|
+$1.77M |
Sector Composition
| 1 | Healthcare | 73.14% |
| 2 | Technology | 21.04% |
| 3 | Energy | 4.89% |
| 4 | Materials | 0.6% |
| 5 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
76
Alumis Inc
ALMS
$2.56B
| – | – |
-10,000
|
|
||
77
Alphatec Holdings
ATEC
$1.18B
| – | – |
-18,058
|
|
||
|
FOLD
78
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-253,000
|
|
||
79
Illumina
ILMN
$25.9B
| – | – |
-6,000
|
|
||
80
Inhibrx
INBX
$1.37B
| – | – |
-3,698
|
|
||
81
Liquidia Corp
LQDA
$4.9B
| – | – |
-10,000
|
|
||
82
Masimo
MASI
$9.36B
| – | – |
-8,280
|
|
||
|
RAPT
83
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-15,000
|
|
||
84
Treace Medical Concepts
TMCI
$225M
| – | – |
-226,947
|
|
||
|
BHVN
85
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-59,365
|
|